Cellular lifespan and regenerative medicine
Source abstract
Abstract
Tissue engineering is a promising approach to aid in the treatment of a wide range of clinical disorders by developing replacement tissues for damaged or diseased organs. Such approaches, however, will require large and functional cell populations in order to produce a tissue that can replicate in vivo function. Most adult cells have limited replicative potential that limits their use in tissue engineering applications. Thus, cell populations with expanded lifespan or increased replicative potential are of interest. Stem cell-derived populations may allow the creation of large cell populations that have increased replicative potential over adult differentiated cells. In addition, ectopic human telomerase reverse transcriptase expression and induced B-cell lymphoma 2 (bcl-2) expression can allow adult cells to proliferate more extensively than unaltered cells. However, concerns for malignant transformation exist with telomerase and bcl-2 approaches. The current states of research in these areas are reviewed as they relate to tissue engineering and the cellular lifespan.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesenchymal stem cell research · Telomeres, Telomerase, and Senescence · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Blood vessels engineered from human cells10.1016/S0140-6736(05)66735-9 ↗
2. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue10.1089/ten.2005.11.120 ↗
3. Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver disease10.1002/hep.20484 ↗
4. Impaired wound repair and delayed angiogenesis in aged mice
5. Vascular cell senescence and vascular aging10.1016/j.yjmcc.2003.11.010 ↗
6. Pancreatic stem cells: differentiation options10.1385/SCR:1:3:265 ↗
7. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse10.1073/pnas.150242297 ↗
8. Extension of lifespan by introduction of telomerase into normal human cells10.1126/science.279.5349.349 ↗
9. Human endothelial cell life extension by telomerase expression10.1074/jbc.274.37.26141 ↗
10. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells10.1038/nbt0602-592 ↗
11. A survey of telomerase activity in human cancer10.1016/S0959-8049(97)00062-2 ↗
12. In vitro hepatic differentiation of human mesenchymal stem cells10.1002/hep.20469 ↗
13. Tissue-engineered bone regeneration10.1038/79449 ↗
14. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells10.1172/JCI12150 ↗
15. Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived precursors10.1016/j.athoracsur.2006.05.066 ↗
16. Vascularization and engraftment of a human skin subsitute using circulating progenitor cell-derived endothelial cells10.1096/fj.05-5682fje ↗
17. Stem cells in tissue engineering10.1038/35102181 ↗
18. Endothelial cells derived from human embryonic stem cells10.1073/pnas.032074999 ↗
19. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes10.1073/pnas.85.18.6622 ↗
20. The serial cultivation of human diploid cell strains10.1016/0014-4827(61)90192-6 ↗
21. The telomere hypothesis of cellular aging10.1016/0531-5565(92)90068-B ↗
22. Telomere shortening in cultured autografts of patients with burns10.1016/S0140-6736(03)13042-5 ↗
23. Expression of hTERT in early premalignant lesions and a subset of cells in normal tissues10.1038/554 ↗
24. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype10.1038/5056 ↗
25. Relevance and safety of telomerase for human tissue engineering10.1073/pnas.0508184103 ↗
26. Immortalization of bovine capillary endothelial cells by hTERT alone involves inactivation of endogenous p16-INK4A/pRB10.1096/fj.02-0599fje ↗
27. Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model10.1093/carcin/bgg076 ↗
28. Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT10.1182/blood-2004-10-4144 ↗
29. Risky immortalization by telomerase10.1038/35015674 ↗
30. Both Rb/p16-INK4A inactivation and telomerase activity are required to immortalize human epithelial cells10.1038/23962 ↗
31. Telomerase is not an oncogene10.1038/sj.onc.1205076 ↗
32. Strict control of telomerase activation using Cre-mediated inversion10.1186/1472-6750-6-10 ↗
33. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery10.1126/science.287.5456.1253 ↗
34. Human POT1 facilitates telomere elongation by telomerase10.1016/S0960-9822(03)00339-7 ↗
35. Antisense inhibition of BCL-2 expressoin induces retinoic acid-mediated cell death during differentiation of human NT2N neurons10.1046/j.1471-4159.2001.00142.x ↗
36. Discrete and complementary mechanisms of protection of beta-cells against cytokine-induced and oxidative damage achieved by bcl-2 overexpression and a cytokine selection strategy10.2337/diabetes.52.6.1423 ↗
37. Influence of Bcl-2 on cell death during the cultivation of a Chinese hamster ovary cell line expressing a chimeric antibody10.1002/(SICI)1097-0290(20000405)68:1<31::AID-BIT4>3.0.CO;2-L ↗
38. Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts10.1161/CIRCULATIONAHA.105.001370 ↗
39. Induction, differentiation and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells10.1073/pnas.0408357102 ↗
40. Accelerated growth and prolonged lifespan of adipose tissue-derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants10.1089/scd.2005.14.92 ↗
41. Identification and reduction of cryoinjury in endothelial cells: a first step toward establishing a cell bank for vascular tissue engineering10.1089/ten.2006.12.3439 ↗
42. The effect of antioxidants and a caspase inhibitor on cryopreserved rat hepatocytes10.3727/000000005783982981 ↗
43. Telomere maintenance and tumorigenesis: an alternative road10.2174/1566524053586653 ↗
44. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines10.1038/nm1197-1271 ↗
45. Homologous recombination generates T-loop-sized deletions at human telomeres10.1016/j.cell.2004.10.011 ↗
46. Telomere lengthening by recombination in human cells10.1038/82586 ↗
47. Alternative lengthening of telomeres in mammalian cells10.1038/sj.onc.1205058 ↗
48. A telomerase component is defective in the human disease dyskeratosis congenital10.1038/990141 ↗
49. Dyskeratosis congenital—a disease of dysfunctional telomere maintenance
50. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA10.1016/S0092-8674(01)80006-4 ↗
51. Muscle regeneration: molecular aspects and therapeutic implications10.1097/00019052-199910000-00007 ↗
52. Telomerase allows the immortalization of T antigen-positive DMD myoblasts: a new source of cells for gene transfer application10.1038/sj.gt.3301132 ↗